Pharmacokinetics of fluoxetine and fluvoxamine in depressed patients: personal results. 1992

S Bouquet, and S Vandel, and G Bertschy, and B Bonin, and B Vandel, and D Sechter, and P Bizouard
Laboratoire de Pharmacocinétique et Pharmacologie Clinique, CHU, Poitiers.

UI MeSH Term Description Entries
D002851 Chromatography, High Pressure Liquid Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed. Chromatography, High Performance Liquid,Chromatography, High Speed Liquid,Chromatography, Liquid, High Pressure,HPLC,High Performance Liquid Chromatography,High-Performance Liquid Chromatography,UPLC,Ultra Performance Liquid Chromatography,Chromatography, High-Performance Liquid,High-Performance Liquid Chromatographies,Liquid Chromatography, High-Performance
D003866 Depressive Disorder An affective disorder manifested by either a dysphoric mood or loss of interest or pleasure in usual activities. The mood disturbance is prominent and relatively persistent. Depression, Endogenous,Depression, Neurotic,Depression, Unipolar,Depressive Syndrome,Melancholia,Neurosis, Depressive,Unipolar Depression,Depressions, Endogenous,Depressions, Neurotic,Depressions, Unipolar,Depressive Disorders,Depressive Neuroses,Depressive Neurosis,Depressive Syndromes,Disorder, Depressive,Disorders, Depressive,Endogenous Depression,Endogenous Depressions,Melancholias,Neuroses, Depressive,Neurotic Depression,Neurotic Depressions,Syndrome, Depressive,Syndromes, Depressive,Unipolar Depressions
D005473 Fluoxetine The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants. Fluoxetin,Fluoxetine Hydrochloride,Lilly-110140,N-Methyl-gamma-(4-(trifluoromethyl)phenoxy)benzenepropanamine,Prozac,Sarafem,Lilly 110140,Lilly110140
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001711 Biotransformation The chemical alteration of an exogenous substance by or in a biological system. The alteration may inactivate the compound or it may result in the production of an active metabolite of an inactive parent compound. The alterations may be divided into METABOLIC DETOXICATION, PHASE I and METABOLIC DETOXICATION, PHASE II.
D016666 Fluvoxamine A selective serotonin reuptake inhibitor that is used in the treatment of DEPRESSION and a variety of ANXIETY DISORDERS. DU-23000,Desiflu,Dumirox,Faverin,Fevarin,Floxyfral,Fluvoxadura,Fluvoxamin AL,Fluvoxamin Stada,Fluvoxamin beta,Fluvoxamin-neuraxpharm,Fluvoxamin-ratiopharm,Fluvoxamina Geminis,Fluvoxamine Maleate,Fluvoxamine Maleate, (E)-Isomer,Fluvoxamine, (Z)-Isomer,Luvox,Novo-Fluvoxamine,Nu-Fluvoxamine,PMS-Fluvoxamine,ratio-Fluvoxamine,DU 23000,DU23000,Fluvoxamin neuraxpharm,Fluvoxamin ratiopharm,Geminis, Fluvoxamina,Novo Fluvoxamine,Nu Fluvoxamine,PMS Fluvoxamine,ratio Fluvoxamine

Related Publications

S Bouquet, and S Vandel, and G Bertschy, and B Bonin, and B Vandel, and D Sechter, and P Bizouard
July 1997, International clinical psychopharmacology,
S Bouquet, and S Vandel, and G Bertschy, and B Bonin, and B Vandel, and D Sechter, and P Bizouard
March 1991, British journal of hospital medicine,
S Bouquet, and S Vandel, and G Bertschy, and B Bonin, and B Vandel, and D Sechter, and P Bizouard
March 1992, The American journal of psychiatry,
S Bouquet, and S Vandel, and G Bertschy, and B Bonin, and B Vandel, and D Sechter, and P Bizouard
October 1990, Journal of clinical psychopharmacology,
S Bouquet, and S Vandel, and G Bertschy, and B Bonin, and B Vandel, and D Sechter, and P Bizouard
January 1995, European archives of psychiatry and clinical neuroscience,
S Bouquet, and S Vandel, and G Bertschy, and B Bonin, and B Vandel, and D Sechter, and P Bizouard
January 1995, L'Encephale,
S Bouquet, and S Vandel, and G Bertschy, and B Bonin, and B Vandel, and D Sechter, and P Bizouard
January 1997, International journal of psychiatry in medicine,
S Bouquet, and S Vandel, and G Bertschy, and B Bonin, and B Vandel, and D Sechter, and P Bizouard
February 1992, Canadian journal of psychiatry. Revue canadienne de psychiatrie,
S Bouquet, and S Vandel, and G Bertschy, and B Bonin, and B Vandel, and D Sechter, and P Bizouard
October 2000, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology,
S Bouquet, and S Vandel, and G Bertschy, and B Bonin, and B Vandel, and D Sechter, and P Bizouard
January 1991, International clinical psychopharmacology,
Copied contents to your clipboard!